Finance

Beta
Lists
SLDB:NASDAQ
Solid Biosciences Inc
$6.70
-7.46%
(-0.54) 1D
Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SLDB...
Open
$7.17
High
$7.20
Low
$6.63
Mkt. cap
659.61M
Avg. vol.
1.10M
Volume
8.00
52-wk high
$8.87
52-wk low
$3.79
EPS
-$1.95
Beta
2.43
Shares outstanding
98.45M
No. of employees
121
Open
$7.17
High
$7.20
Low
$6.63
Mkt. cap
659.61M
Avg. vol.
1.10M
Volume
8.00
52-wk high
$8.87
52-wk low
$3.79
EPS
-$1.95
Beta
2.43
Shares outstanding
98.45M
No. of employees
121
Analyst outlook
Analyst Ratings
Based on 11 analysts giving stock ratings to SLDB in the past 3 months
Strong Buy
Buy
11
Hold
0
Sell
0
12 month forecast
Based on 11 Wall Street analysts offering 12 month price targets for SLDB in the last 3 months.
Highest
Current $6.70
$26.00 (+288.06%)
Average
$17.78 (+165.37%)
Lowest
$11.00 (+64.18%)
News stories
From sources across the web
About Solid Biosciences Inc
CEO-
Employees121
Founded2013
Headquarters-
SectorBiotechnology
Websitesolidbio.com
Last report
May 12, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.52 / -$0.44
-18.63%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
32.42M
38.86M
38.14M
46.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.28M
9.20M
11.27M
11.17M
Operating expense
41.69M
48.06M
49.40M
57.31M
Total operating expenses
41.69M
48.06M
49.40M
57.31M
Operating income
-41.69M
-48.06M
-49.40M
-57.31M
Other non operating income
-693.00K
-304.00K
-2.44M
-1.49M
EBT including unusual items
-39.48M
-45.78M
-49.79M
-56.74M
EBT excluding unusual items
-39.48M
-45.78M
-49.79M
-56.74M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-39.48M
-45.78M
-49.79M
-56.74M
Net profit margin
-
-
-
-
Earnings per share
-0.42
-0.48
-0.53
-0.52
Interest and investment income
2.97M
2.59M
2.05M
2.06M
Interest expense
-60.00K
-
-
-
Net interest expenses
2.91M
2.59M
2.05M
2.06M
Depreciation and amortization charges
-
-
-
-
EBITDA
-41.31M
-47.68M
-48.94M
-56.91M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer